Analgesics - India

  • India
  • Revenue in the Analgesics market amounts to €1.04bn in 2024. The market is expected to grow annually by 9.40% (CAGR 2024-2029).
  • In global comparison, most revenue is generated in the United States (€6,716m in 2024).
  • In relation to total population figures, per person revenues of €0.72 are generated in 2024.

Key regions: Thailand, Europe, Germany, India, United States

 
Mercado
 
Región
 
Comparación de regiones
 
Moneda
 

Analyst Opinion

Although the COVID-19 pandemic resulted in a reduction of selective procedures and surgeries, which leads to a decreasing sale of after-surgical pain killers, COVID-19-related symptoms such as muscle or body aches are driving the demand during the pandemic. In 2022, the global Analgesics market reached US$30.93 billion and recovered from a slight decline in 2020 brought about by the COVID-19 pandemic.

Another significant trend is the prevalence of chronic diseases, which leads to a growing demand for analgesics used by people suffering from chronic and severe pain. The growth of the Analgesics market is restricted by legislation, as the restriction on opioid analgesics differs from country to country.

In the forecast period, the market exhibits steady growth at a CAGR of around 6%, mainly based on the globally growing share of the elderly population and the correspondingly increasing demand. The global Analgesics market is expected to reach US$42.65 billion in 2027.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Visión general

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Espere, por favor

Contacto

¿Alguna duda? Estaremos encantados de atenderte.
Statista Locations
Contacto Nerea Marcos
Nerea Marcos
Client Success Manager

Lu - vi, 9:30 - 17:00 h (CET)

Contacto Meredith Alda
Meredith Alda
Sales Manager– Contacto (Estados Unidos)

Lu - vi, 9:00 - 18:00 h (EST)

Contacto Yolanda Mega
Yolanda Mega
Operations Manager– Contacto (Asia)

Lu - vi, 9:00 - 17:00 h (SGT)

Contacto Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contacto (Asia)

Lu - vi, 10:00 - 18:00 h (JST)

Contacto Lodovica Biagi
Lodovica Biagi
Director of Operations– Contacto (Europa)

Lu - vi, 9:30 - 17:00 h (GMT)

Contacto Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contacto (América Latina)

Lu - vi, 9:00am-6:00pm (EST)